Research Article
Split Viewer
Mol. Cells 2010; 29(1): 51-56
Published online January 31, 2010
https://doi.org/10.1007/s10059-010-0016-0
© The Korean Society for Molecular and Cellular Biology
Expression of p25, an Aberrant Cyclin-Dependent Kinase 5 Activator, Stimulates Basal Secretion in PC12 Cells
Correspondence to : *Correspondence: sulchung@inje.ac.kr
Although alterations in the functions of neurotransmitter systems have been implicated in the pathology of Alzhei-mer’s disease (AD), the mechanisms that give rise to these alterations are not well understood. The amount of p25, an aberrant cleavage product of p35 that activates cyclin-dependent kinase 5 (Cdk5), is elevated in AD brains. The role of Cdk5 in neurotransmitter release has been well established. In this study, we examined whether p25 was linked to altered neurotransmitter release in AD. Transient or stable expression of p25 significantly increased basal secretion of human growth hormone (hGH) or neurotransmitter in PC12 cells. Expression of a p25 phosphorylation-deficient mutant, T138A, inhibited basal hGH secretion relative to the p25 wild type, suggesting the involvement of Thr138 phosphorylation in secretion. The expression and activity of
Keywords Alzheimer’s disease, Cdk5, p25, PC12 cells, secretion
PDF
Standard view
Export citation
Share Article
Research Article
Mol. Cells 2010; 29(1): 51-56
Published online January 31, 2010 https://doi.org/10.1007/s10059-010-0016-0
Copyright © The Korean Society for Molecular and Cellular Biology.
Expression of p25, an Aberrant Cyclin-Dependent Kinase 5 Activator, Stimulates Basal Secretion in PC12 Cells
Mi-Young Son1,2, and Sul-Hee Chung1,*
1Graduate Program in Neuroscience, Institute for Brain Science and Technology, Inje University, Busan 614-735, Korea, 2Present address: Development and Differentiation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea; Department of Biological Sciences, Korean Advanced Institute of Science and Technology, Daejeon 305-701, Korea
Correspondence to:*Correspondence: sulchung@inje.ac.kr
Abstract
Although alterations in the functions of neurotransmitter systems have been implicated in the pathology of Alzhei-mer’s disease (AD), the mechanisms that give rise to these alterations are not well understood. The amount of p25, an aberrant cleavage product of p35 that activates cyclin-dependent kinase 5 (Cdk5), is elevated in AD brains. The role of Cdk5 in neurotransmitter release has been well established. In this study, we examined whether p25 was linked to altered neurotransmitter release in AD. Transient or stable expression of p25 significantly increased basal secretion of human growth hormone (hGH) or neurotransmitter in PC12 cells. Expression of a p25 phosphorylation-deficient mutant, T138A, inhibited basal hGH secretion relative to the p25 wild type, suggesting the involvement of Thr138 phosphorylation in secretion. The expression and activity of
Keywords: Alzheimer’s disease, Cdk5, p25, PC12 cells, secretion
Previous Article
Article Tools
Stats or Metrics
Share this article on
Related articles in Mol. Cells
-
Critical Roles of Deubiquitinating Enzymes in the Nervous System and Neurodegenerative Disorders
Soumyadip Das, Suresh Ramakrishna, and Kye-Seong Kim
Mol. Cells 2020; 43(3): 203-214 https://doi.org/10.14348/molcells.2020.2289 -
ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer’s Disease
Woojin Jeong, Hyein Lee, Sukhee Cho, and Jinsoo Seo
Mol. Cells 2019; 42(11): 739-746 https://doi.org/10.14348/molcells.2019.0200 -
Effects of δ-Catenin on APP by Its Interaction with Presenilin-1
Weiye Dai, Taeyong Ryu, Hangun Kim, Yun Hye Jin, Young-Chang Cho, and Kwonseop Kim
Mol. Cells 2019; 42(1): 36-44 https://doi.org/10.14348/molcells.2018.0273
